Brakenhoff RH - Search Results

1

Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions.

Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Braakhuis BJ, et al. Among authors: brakenhoff rh. Head Neck. 2002 Feb;24(2):198-206. doi: 10.1002/hed.10042. Head Neck. 2002. PMID: 11891950 Review.

2

Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.

Gripp FM, Quak J, Leverstein H, Schrijvers A, Gerretsen M, Brakenhoff R, Van Dongen G, Snow GB, Rapoport A. Gripp FM, et al. Sao Paulo Med J. 1994 Jul-Sep;112(3):612-21. doi: 10.1590/s1516-31801994000300008. Sao Paulo Med J. 1994. PMID: 7638523 Review. No abstract available.

3

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.

Brakenhoff RH, van Gog FB, Looney JE, van Walsum M, Snow GB, van Dongen GA. Brakenhoff RH, et al. Cancer Immunol Immunother. 1995 Mar;40(3):191-200. doi: 10.1007/BF01517351. Cancer Immunol Immunother. 1995. PMID: 7728778 Free PMC article.

4

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Gerretsen M, Visser GW, Brakenhoff RH, van Walsum M, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: brakenhoff rh. Cell Biophys. 1994;24-25:135-42. doi: 10.1007/BF02789224. Cell Biophys. 1994. PMID: 7736517

5

The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.

Brakenhoff RH, Gerretsen M, Knippels EM, van Dijk M, van Essen H, Weghuis DO, Sinke RJ, Snow GB, van Dongen GA. Brakenhoff RH, et al. J Cell Biol. 1995 Jun;129(6):1677-89. doi: 10.1083/jcb.129.6.1677. J Cell Biol. 1995. PMID: 7790363 Free PMC article.

6

The feasibility of radioimmunotherapy of head and neck cancer.

Gerretsen M, Quak JJ, Brakenhoff RH, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: brakenhoff rh. Eur J Cancer B Oral Oncol. 1994;30B(2):82-7. doi: 10.1016/0964-1955(94)90057-4. Eur J Cancer B Oral Oncol. 1994. PMID: 8032305

7

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.

Van Hal NL, Van Dongen GA, Rood-Knippels EM, Van Der Valk P, Snow GB, Brakenhoff RH. Van Hal NL, et al. Among authors: brakenhoff rh. Int J Cancer. 1996 Nov 15;68(4):520-7. doi: 10.1002/(SICI)1097-0215(19961115)68:4<520::AID-IJC19>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8945625

8

Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.

van Gog FB, Brakenhoff RH, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: brakenhoff rh. Cancer Immunol Immunother. 1997 Apr;44(2):103-11. doi: 10.1007/s002620050362. Cancer Immunol Immunother. 1997. PMID: 9177472 Free PMC article.

9

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

Braakhuis BJ, Klaassen I, van der Leede BM, Cloos J, Brakenhoff RH, Copper MP, Teerlink T, Hendriks HF, van der Saag PT, Snow GB. Braakhuis BJ, et al. Among authors: brakenhoff rh. Br J Cancer. 1997;76(2):189-97. doi: 10.1038/bjc.1997.361. Br J Cancer. 1997. PMID: 9231918 Free PMC article.

10

Biologic implications of genetic changes in head and neck squamous cell carcinogenesis.

Reid CB, Snow GB, Brakenhoff RH, Braakhuis BJ. Reid CB, et al. Among authors: brakenhoff rh. Aust N Z J Surg. 1997 Jul;67(7):410-6. doi: 10.1111/j.1445-2197.1997.tb02004.x. Aust N Z J Surg. 1997. PMID: 9236604 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters